Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model-Reference-Cited by-同舟云学术

Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model

Published:2017-05-17 Issue:5 Volume:18 Page:1072
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Salvalaio Marika,D’Avanzo Francesca,Rigon Laura,Zanetti Alessandra,D’Angelo Michela,Valle Giorgio,Scarpa Maurizio,Tomanin Rosella

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/5/1072/pdf

Reference80 articles.

1. Multidisciplinary Management of Hunter Syndrome

2. The Lysosome as a Regulatory Hub

3. The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome)

4. Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry

5. IDS Crossing of the Blood-Brain Barrier Corrects CNS Defects in MPSII Mice

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy–lysosomal-associated neuronal death in neurodegenerative disease;Acta Neuropathologica;2024-09-11

2. Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond;BioDrugs;2024-08-23

3. Challenges and opportunities in neurometabolic disease treatment with enzyme delivery;Expert Opinion on Drug Delivery;2024-06-02

4. Mature neurons from iPSCs unveil neurodegeneration-related pathways in mucopolysaccharidosis type II: GSK-3β inhibition for therapeutic potential;Cell Death & Disease;2024-04-29

5. Mucopolysaccharidosis type II zebrafish model exhibits early impaired proteasomal-mediated degradation of the axon guidance receptor Dcc;Cell Death & Disease;2024-04-16